Martin Charles Faulkes, Director at VOLITIONRX LTD (VNRX), bought 9,716 shares at $1.28 ($12K) on 2023-08-31, disclosed to the SEC on 2023-09-01.
Open-market purchase of $12k VNRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| VNRX | BUY | 2019-08-28 | $38K | — | Filing → |
| VNRX | BUY | 2019-08-16 | $197K | — | Filing → |
| VNRX | BUY | 2019-06-13 | $461K | — | Filing → |